Insulin Attenuates Diabetes-Related Mitochondrial Alterations: A Comparative Study
Abstract
This study evaluated and compared the effect of insulin treatment on the status of brain, heart and kidney mitochondria isolated from 12-week streptozotocin (STZ)-induced diabetic rats versus STZ-diabetic animals treated with insulin during a period of 4 weeks. Mitochondria isolated from 12-week citrate (vehicle)-treated rats were used as control. Several mitochondrial parameters were evaluated: respiratory indexes (state 3 and 4 of respiration, respiratory control and ADP/O ratios), transmembrane potential, depolarization and repolarization levels, ATP, glutathione and coenzyme Q contents, production of hydrogen peroxide, superoxide dismutase, glutathione peroxidase and glutathione reductase activities and the ability of mitochondria to accumulate calcium. We observed that diabetes promoted a significant decrease in kidney and brain mitochondrial coenzyme Q9 content while this parameter was increased in heart mitochondria. Furthermore, diabetes induced a significant increase in hydrogen peroxide production in kidney mitochondria this effect being accompanied by a significant increase in glutathione peroxidase and reductase activities. Furthermore, brain mitochondria isolated from diabetic animals presented a lower ATP content and ability to accumulate calcium. In contrast, heart and kidney mitochondria presented a slight higher capacity to accumulate calcium. Insulin treatment normalized the levels of coenzyme Q9 and glutathione peroxidase and reductase activities and increased ATP content and the ability to accumulate calcium. Altogether these results suggest that insulin treatment attenuates diabetes-induced mitochondrial alterations protecting against the increase in oxidative stress and improving oxidative phosphorylation efficiency. In this line, insulin therapy, besides its well-known importance in the maintenance of glycemic control, may help to protect against mitochondrial dysfunction associated to several age-related disorders such as diabetes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In heart and kidney mitochondria from STZ diabetic rats, no significant change in respiration is observed.
“More recent studies of heart and kidney mitochondria from STZ diabetic rats revealed no significant change in respiration (223).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [223]
The decreased state 3 and state 4 respiration observed in brain mitochondria from streptozotocin-treated rats were not observed in kidney mitochondria.
“These changes were not observed in kidney mitochondria.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [223]
There is no increase in H2O2 production by brain mitochondria isolated from 12-week streptozotocin diabetic rats.
“Moreira et al. (223) reported no increase in H2O2 production by brain mitochondria isolated from 12-week streptozotocin diabetic rats.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [223]
The citation lists haven’t been fetched yet
References 2 · Cited by 54
- Authors
- Moreira, P., Rolo, A., Sena, C., Seica, R., Oliveira, C., & Santos, M.
- Affiliations
- Centro de Neurociências e Biologia Celular (PT)
- University of Coimbra (PT)
- Corresponding author
- Santos, M.
- Venue
- Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2006-05-01
- Volume
- 2
- Issue
- 3
- Pages
- 299-308
- ISSN
- 1573-4064 (ISSN-L)
- OpenAlex
- W2143258411
- Cited by
- 54
- References
- 2
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 6 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 6 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 6 · 2012: 3
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação para a Ciência e a Tecnologia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Keywords
- insulin therapy, diabetes mellitus, mitochondrial dysfunction, streptozotocin-induced diabetes, coenzyme Q9, oxidative stress, hydrogen peroxide, glutathione peroxidase, glutathione reductase, mitochondrial calcium accumulation, ATP levels, mitochondrial respiration, membrane potential, brain mitochondria, heart mitochondria, kidney mitochondria
- MeSH terms
- Animals, Body Weight, Brain, Calcium, Diabetes Mellitus, Experimental, Insulin, Male, Mitochondria, Organ Size, Phosphorylation, Streptozocin, Rats, Wistar, Oxidative Stress, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review